Physician profile
Warren Selman
NPI 1679599542
$11,528.89
in general payments reported to CMS, 2019-2025
12 companies · $1,841 in 2025
The $1,841 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,800 · 2020: $4,857 · 2022: $1,759 · 2023: $364 · 2024: $908 · 2025: $1,841.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,598 · Food and Beverage: $1,515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,597.96 |
| Food and Beverage | $1,515.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $6,600.00 | 2019-2020 | |
| Medtronic, INC. | $3,962.48 | 2022-2025 | Stealthstation S8 Platform, Mazor X System, Linq II |
| Nuvasive, INC. | $258.88 | 2022 | |
| Surgical Theater. INC. | $138.97 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $122.55 | 2024 | Andexxa |
| Cerapedics INC. | $112.61 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Integra Lifesciences Corporation | $112.12 | 2025 | Codman Certas, Codman Hakim, Cusa Clarity |
| Ceribell, INC. | $62.14 | 2025 | Pocket Eeg Device |
| Elekta, INC. | $56.76 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $47.40 | 2025 | Exparel |
| Abbvie INC. | $39.92 | 2024 | |
| Springworks Therapeutics, INC. | $15.06 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$45,214.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Warren Selman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.